Exenatide reduces urinary transforming growth factor-β1 and type IV collagen excretion in patients with type 2 diabetes and microalbuminuria. (Q51355700)
Jump to navigation
Jump to search
scientific article published on 8 June 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Exenatide reduces urinary transforming growth factor-β1 and type IV collagen excretion in patients with type 2 diabetes and microalbuminuria. |
scientific article published on 8 June 2012 |
Statements
Exenatide reduces urinary transforming growth factor-β1 and type IV collagen excretion in patients with type 2 diabetes and microalbuminuria. (English)
1 reference
Hong Zhang
1 reference
Xiangcheng Zhang
1 reference
Changjun Hu
1 reference
Weiping Lu
1 reference
8 June 2012
1 reference
35
1 reference
6
1 reference
483-488
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference